These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20349162)

  • 1. Elevated osteopontin expression and proliferative/apoptotic ratio in the colorectal adenoma-dysplasia-carcinoma sequence.
    Valcz G; Sipos F; Krenács T; Molnár J; Patai AV; Leiszter K; Tóth K; Solymosi N; Galamb O; Molnár B; Tulassay Z
    Pathol Oncol Res; 2010 Dec; 16(4):541-5. PubMed ID: 20349162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes.
    Galamb O; Sipos F; Spisák S; Galamb B; Krenács T; Valcz G; Tulassay Z; Molnár B
    Cell Oncol; 2009; 31(1):19-29. PubMed ID: 19096147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation and apoptosis in proliferative lesions of the colon and rectum.
    Kikuchi Y; Dinjens WN; Bosman FT
    Virchows Arch; 1997 Aug; 431(2):111-7. PubMed ID: 9293892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butyrate suppresses mRNA increase of osteopontin and cyclooxygenase-2 in human colon tumor tissue.
    Jahns F; Wilhelm A; Jablonowski N; Mothes H; Radeva M; Wölfert A; Greulich KO; Glei M
    Carcinogenesis; 2011 Jun; 32(6):913-20. PubMed ID: 21459756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
    Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
    Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis.
    Yu HG; Yu LL; Yang Y; Luo HS; Yu JP; Meier JJ; Schrader H; Bastian A; Schmidt WE; Schmitz F
    Oncology; 2003; 65(1):37-45. PubMed ID: 12837981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
    Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
    Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.
    Sillars-Hardebol AH; Carvalho B; Beliën JA; de Wit M; Delis-van Diemen PM; Tijssen M; van de Wiel MA; Pontén F; Meijer GA; Fijneman RJ
    Cell Oncol (Dordr); 2012 Aug; 35(4):293-300. PubMed ID: 22711543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of methylated septin 9 gene on RNA and protein level in colorectal cancer.
    Tóth K; Galamb O; Spisák S; Wichmann B; Sipos F; Valcz G; Leiszter K; Molnár B; Tulassay Z
    Pathol Oncol Res; 2011 Sep; 17(3):503-9. PubMed ID: 21267688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of the human osteopontin promoter by ERRα in colorectal cancer.
    Boudjadi S; Bernatchez G; Beaulieu JF; Carrier JC
    Am J Pathol; 2013 Jul; 183(1):266-76. PubMed ID: 23680656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of CD10 in cancer-associated fibroblasts and its effect on initiation and progression of colorectal carcinoma].
    Zhu Y; Zheng JJ; Yang F; Nie QQ; Zhu ZL; Deng H
    Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):859-865. PubMed ID: 28056302
    [No Abstract]   [Full Text] [Related]  

  • 12. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
    Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
    BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic down-regulation of Krüppel-like factor 4 in colorectal adenoma-carcinoma sequence.
    Xu J; Lü B; Xu F; Gu H; Fang Y; Huang Q; Lai M
    J Cancer Res Clin Oncol; 2008 Aug; 134(8):891-8. PubMed ID: 18264726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.
    Herszényi L; Sipos F; Galamb O; Solymosi N; Hritz I; Miheller P; Berczi L; Molnár B; Tulassay Z
    Pathol Oncol Res; 2008 Mar; 14(1):31-7. PubMed ID: 18347934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 expression in colorectal adenomas.
    Sato T; Yoshinaga K; Okabe S; Okawa T; Enomoto M; Takizawa T; Sugihara K
    Dis Colon Rectum; 2003 Jun; 46(6):786-92. PubMed ID: 12794581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of CSE1L Gene in Colorectal Cancer Reduces Tumorigenesis in Vitro.
    Pimiento JM; Neill KG; Henderson-Jackson E; Eschrich SA; Chen DT; Husain K; Shibata D; Coppola D; Malafa MP
    Am J Pathol; 2016 Oct; 186(10):2761-8. PubMed ID: 27521996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant cytological localization of p16 and CDK4 in colorectal epithelia in the normal adenoma carcinoma sequence.
    Zhao P; Mao X; Talbot IC
    World J Gastroenterol; 2006 Oct; 12(39):6391-6. PubMed ID: 17072968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence.
    Chell SD; Witherden IR; Dobson RR; Moorghen M; Herman AA; Qualtrough D; Williams AC; Paraskeva C
    Cancer Res; 2006 Mar; 66(6):3106-13. PubMed ID: 16540660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of expression of hRFI on adenoma formation and tumor progression in colorectal adenoma-carcinoma sequence.
    Sasaki S; Watanabe T; Konishi T; Kitayama J; Nagawa H
    J Exp Clin Cancer Res; 2004 Sep; 23(3):507-12. PubMed ID: 15595643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer.
    Sipos F; Germann TM; Wichmann B; Galamb O; Spisák S; Krenács T; Tulassay Z; Molnár B; Műzes G
    Eur J Cancer Prev; 2014 Sep; 23(5):336-43. PubMed ID: 24999605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.